Literature DB >> 29269942

A dynamic map for learning, communicating, navigating and improving therapeutic development.

John Wagner1, Andrew M Dahlem2, Lynn D Hudson3, Sharon F Terry4, Russ B Altman5, C Taylor Gilliland6, Christopher DeFeo7, Christopher P Austin6.   

Abstract

Mesh：

Year:  2017        PMID： 29269942     DOI： 10.1038/nrd.2017.217

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  3 in total

Review 1.  How to improve R&D productivity: the pharmaceutical industry's grand challenge.

Authors:  Steven M Paul; Daniel S Mytelka; Christopher T Dunwiddie; Charles C Persinger; Bernard H Munos; Stacy R Lindborg; Aaron L Schacht
Journal:  Nat Rev Drug Discov       Date:  2010-02-19       Impact factor: 84.694

Review 2.  An end to the myth: there is no drug development pipeline.

Authors:  Kristin Baxter; Elizabeth Horn; Neely Gal-Edd; Kristi Zonno; James O'Leary; Patrick F Terry; Sharon F Terry
Journal:  Sci Transl Med       Date:  2013-02-06       Impact factor: 17.956

3.  Application of a Dynamic Map for Learning, Communicating, Navigating, and Improving Therapeutic Development.

Authors:  John A Wagner; Andrew M Dahlem; Lynn D Hudson; Sharon F Terry; Russ B Altman; C Taylor Gilliland; Christopher DeFeo; Christopher P Austin
Journal:  Clin Transl Sci       Date:  2017-12-22       Impact factor: 4.689
  3 in total
  8 in total

1.  Translational misconceptions.

Authors:  Christopher P Austin
Journal:  Nat Rev Drug Discov       Date:  2021-07       Impact factor: 84.694

2.  Translating translation.

Authors:  Christopher P Austin
Journal:  Nat Rev Drug Discov       Date:  2018-04-20       Impact factor: 84.694

3.  Application of Machine Learning in Translational Medicine: Current Status and Future Opportunities.

Authors:  Nadia Terranova; Karthik Venkatakrishnan; Lisa J Benincosa
Journal:  AAPS J       Date:  2021-05-18       Impact factor: 4.009

Review 4.  Microphysiological systems: What it takes for community adoption.

Authors:  Passley Hargrove-Grimes; Lucie A Low; Danilo A Tagle
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-25

5.  How to produce 'marketable and profitable results for the company': from viral interference to Roferon A.

Authors:  Carsten Timmermann
Journal:  Hist Philos Life Sci       Date:  2019-07-30       Impact factor: 1.205

6.  Vaccine innovation model: A technology transfer perspective in pandemic contexts.

Authors:  Maurício Z Medeiros; Priscila F Soares; Beatriz C Fialho; Leandro Gauss; Fábio S Piran; Daniel P Lacerda
Journal:  Vaccine       Date:  2022-06-27       Impact factor: 4.169

Review 7.  Alternative strategies in cardiac preclinical research and new clinical trial formats.

Authors:  Fabian Philipp Kreutzer; Anna Meinecke; Kevin Schmidt; Jan Fiedler; Thomas Thum
Journal:  Cardiovasc Res       Date:  2022-02-21       Impact factor: 10.787

Review 8.  Opportunities and challenges in translational science.

Authors:  Christopher P Austin
Journal:  Clin Transl Sci       Date:  2021-07-08       Impact factor: 4.689
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.